Healthy Skepticism Library item: 10186

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

O'Dowd A.
Cost of some types of prescribed drug can vary fourfold across England, audit shows
BMJ 2007 May 26; 334:(7603):1076
http://www.bmj.com/cgi/content/full/334/7603/1076-a

Abstract:

Up to £300m (440m; $590m) could be saved every year in England through smarter prescribing by GPs, the government’s spending watchdog said last week.

The National Audit Office (NAO) has published a report saying that smarter prescribing-and particularly the prescribing of generic drugs-could save primary care trusts more than £200m a year, and cutting back on unused drugs could save a further £100m.

For the report the NAO surveyed 1000 GPs, polled advisers on prescribing in primary care trusts, analysed prescriptions written between August 2005 and July 2006, and interviewed GPs, NHS trusts, academics, pharmacists, and the drug industry.

The report identifies wide variation among trusts in the extent to which local GPs prescribe cheaper drugs for the same conditions.

The authors analysed the way in which four common types of drug were prescribed. They looked at:

The percentage of statins prescribed as generic simvastatin

The percentage of drugs . . .